Neuraxpharm’s Brain Acquisition Stems From Expansion Ambitions
CNS Specialist ‘Now Able To Bring New Products To The Greek Market’
Privately-owned Neuraxpharm has found another company to give it further access to a new European market, picking up Athens-based Brain Therapeutics. It aims now to introduce its Buccolam (midazolam) in Greece.
